News

A 60% increase in pallet storage capability

Master data on prescribers is combined with tracking expenditures, for transparency reporting

An estimated 64,070 deaths recorded; meanwhile, private equity flows into addiction centers

First gene therapy product in US; approval expedited by evidence of high cure rates

Investors hope for a repeat of Gilead’s Sovaldi success

Company is targeting a treatment for glioblastoma; Phase I to begin next year

Pharma needs better internal policies to manage its increasing patient interaction

In the midst of the opioid crisis, drug distributors need to address DEA oversight

Observers are critical of the $465-million penalty as too lenient

Is the accelerated-approval process providing a net benefit to patients?

Specialized conditioning technology simplifies the shipment prep work

CEIV Pharma certification; expanded temperature regimes and better calibration capabilities

A protest against not protesting; unclear consequences for pharma’s place on the White House council

Oncology, obesity control and respiratory therapy are the first targets

New location, following Brexit, will be decided in November

Firm has quintupled its Indianapolis facility over two years

Pharma traceability company will expand global presence

Meanwhile, opioid manufacturers and distributors contend with multiple DEA penalties

Action better integrates warehouse operations into pharma traceability

Electronic signatures, a call-center telephony system and secure fax technology are being provided

Site lists manufacturers’ policies and criteria for experimental access

Shipping containers for cold-chain pharmaceuticals and biologics

GPO for academic medical centers and other providers

95% of consumers don’t know about online pharmacy certification

August, December and February meetings target unresolved technical issues

Cambridge BioMarketing brings orphan-drug expertise, and Vynamic brings branding and launch services

Veeva-led group is developing nonproprietary identity- and consent-management standards for HCPs

GAO report notes FDA’s 99% acceptance rate for ‘expanded access’, but legislators press on